IRBENIDA PLUS
Film-coated tablet, 150mg/12.5mg
RxActive license
Active substance (INN)
hydrochlorothiazideirbesartan
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength150mg/12.5mg
PackagingUkupno 30 film tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerHemofarm a.d. Vršac, Serbia
Therapeutic groupCardiovascular system (C09DA04)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJanuary 21, 2026
Analogs in Montenegro
20Other medicines with the same active substance
AMPRIL HDRx
Tablet, 5mg + 25mgAMPRIL HLRx
Tablet, 2.5mg + 12.5mgCO-DIOVANRx
Film-coated tablet, 80mg + 12.5mgENAP-HRx
Tablet, 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 12.5mgFLIRKANORx
Film-coated tablet, 320mg + 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 12.5mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 25mgIRBENIDARx
Film-coated tablet, 300mgIRBENIDARx
Film-coated tablet, 150mgIRBENIDA PLUSRx
Film-coated tablet, 300mg/12.5mgIRUZIDRx
Tablet, 10mg + 12.5mgIRUZIDRx
Tablet, 20mg + 12.5mgLODOZRx
Film-coated tablet, 2.5mg + 6.25mgLODOZRx
Film-coated tablet, 5mg + 6.25mgLODOZRx
Film-coated tablet, 10mg + 6.25mgLOPRIL HRx
Tablet, 20mg + 12.5mgLOPRIL HRx
Tablet, 10mg + 12.5mgLORISTA HRx
Film-coated tablet, 50mg + 12.5mgSource: CInMED register